• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

• 페이스북 공유
• 트위터 공유
• 

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medications during pregnancy and breastfeeding is challenging for women with the condition. There aren't enough data regarding how exposure over time may affect the foetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to generic adhd medications medication during pregnancy do not develop neurological problems like hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge the need for more high-quality studies.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication should consider the benefits of taking it against the possible risks to the fetus. Physicians don't have the data to give clear advice however they can provide information on the risks and benefits to aid pregnant women in making informed decisions.

A study published in Molecular Psychiatry concluded that women who were taking adhd medication how does it work medication during their early pregnancy did not have a higher risk of fetal malformations, or structural birth defects. Researchers used a large population-based study of case control to assess the frequency of major structural defects in infants who were born to mothers who used stimulants during pregnancy. Pediatric cardiologists and clinical geneticists looked over the cases to ensure accurate classification of the cases and to reduce the possibility of bias.

The study of the researchers had some limitations. The researchers were unable, in the first place to distinguish the effects triggered by the medication from the disorder. This limitation makes it difficult for researchers to determine if the few associations observed between the groups that were exposed to medication use or if they were affected by comorbidities. Researchers also did not study long-term outcomes for the offspring.

The study showed that infants whose mother had taken ADHD medication during pregnancy had a slightly higher risk of admission to the neonatal care unit (NICU) as compared to mothers who didn't take any medication during pregnancy, or had quit taking the medication prior to or during pregnancy. This was due to central nervous system-related disorders, and the higher risk of admission was not found to be influenced by which stimulant medications were taken during pregnancy.

Women who took stimulant ADHD medication during pregnancy also had an increased risk of having a caesarean section or having a child with a low Apgar score (less than 7). These increases did appear to be independent of the type of medication used during pregnancy.

The researchers suggest that the small risk associated with the use of ADHD medications during the early stages of pregnancy could be offset by the greater benefits to both the mother and child from continued treatment for the woman's disorder. Doctors should discuss with their patients about this issue and, if possible, help them develop coping skills that may reduce the effects of her disorder on her daily functioning and her relationships.

Medication Interactions

As more women than ever are being diagnosed with ADHD and treated with medication, the dilemma of whether to continue or stop treatment during pregnancy is a question that more and more physicians confront. These decisions are often made without clear and authoritative evidence. Instead, doctors have to take into account their own experience, the experience of other physicians and the research on the topic.

The issue of risk to infants is extremely difficult. The research that has been conducted on this topic is based on observations instead of controlled studies and a lot of the results are contradictory. Most studies restrict their analysis to live births, which may underestimate the teratogenic impact leading to abortions or terminations of pregnancy. The study presented in this journal club addresses these shortcomings by analyzing data on live and deceased births.

Conclusion A few studies have found a positive correlation between ADHD medications and certain birth defects however, other studies haven't found a correlation. The majority of studies show an unintended, or slightly negative, impact. In the end an accurate risk-benefit analysis is required in every instance.

For a lot of women with ADHD and ADD, the decision to stop medication is difficult if not impossible. In a recent article in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of loneliness and family conflict for these patients. A decrease in medication could also impact the ability to drive safely and to perform work-related tasks which are crucial aspects of everyday life for people with ADHD.

She suggests women who are uncertain about whether to continue or stop medication in light of their pregnancy should consider the possibility of educating friends, family members and colleagues about the condition, its effects on daily functioning, and the advantages of staying on the current treatment regimen. Educating them can also aid in ensuring that the woman feels supported as she struggles with her decision. It is important to note that certain medications are able to be absorbed through the placenta so if the patient decides to stop her ADHD medication during pregnancy and breastfeeding, she should be aware that traces of the medication could be passed on to the baby.

Birth Defects and Risk of

As the use of adhd medication names list medication to treat the symptoms of attention deficit hyperactivity disorder (common adhd medications uk (similar webpage)) grows, so do concerns about what impact the drugs might have on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this subject. Utilizing two huge data sets researchers were able examine more than 4.3 million pregnancies and see whether stimulant medication use increased the risk of birth defects. Although the risk overall remains low, the scientists found that exposure in the first trimester to ADHD medicines was associated with a slightly higher rate of certain heart defects, such as ventriculoseptal defect (VSD).

The authors of the study didn't discover any connection between the use of early medications and other congenital anomalies, like facial deformities, or club feet. The results are in the same vein as previous studies that have shown an insignificant, but small increase in the number of cardiac malformations among women who started taking ADHD medication prior to the time of the time of pregnancy. The risk was higher in the latter half of pregnancy, when a lot of women are forced to stop taking their ADHD medications.

Women who used ADHD medications during the first trimester of pregnancy were also more likely to undergo caesarean sections, a low Apgar score following delivery, and a baby who needed help breathing at birth. The researchers of the study could not eliminate bias due to selection because they limited their study to women who did not have any other medical conditions that could have contributed to the findings.

The researchers hope their study will aid in the clinical decisions of doctors who encounter pregnant women. They suggest that although a discussion of the benefits and risks is important however, the decision to stop or continue treatment should be based on each woman's needs and the severity of her ADHD symptoms.

The authors also warn that even though stopping the medication is an alternative, it is not an option that is recommended due to the high prevalence of depression and other mental health problems for women who are expecting or postpartum. Further, research shows that women who stop taking their medications will have a tough transitioning to life without them once the baby is born.

Nursing

It can be a stressful experience to become a mom. Women with ADHD who have to manage their symptoms while attending physician appointments, preparing for the arrival of a child and adjusting to new household routines may face a lot of challenges. Many women decide to continue taking their ADHD medication during pregnancy.

The majority of stimulant medications are absorbed through breast milk in small amounts, so the risk to nursing infant is very low. However, the frequency of exposure to medication by the newborn can vary depending on dosage, frequency it is administered and at what time the medication is administered. Additionally, different medications enter the body of the baby differently through the gastrointestinal tract and breast milk, and the effect of this on a newborn isn't fully understood.

Because of the lack of research, some physicians may be inclined to discontinue stimulant medication during the pregnancy of a woman. It is a difficult decision for the woman, who must weigh the benefits of her medication against the risks to the fetus. Until more information becomes available, doctors can inquire about pregnant patients if they have any background of adhd medication titration or if they plan to take medication in the perinatal stage.

Numerous studies have demonstrated that women can continue to take their ADHD medication in a safe manner during pregnancy and while breast-feeding. In the end, an increasing number of patients opt to do this and, after consulting with their doctor, they have found that the benefits of keeping their current medication exceed any risk.

Women who suffer from ADHD who are planning to breastfeed should seek advice from a specialist psychiatrist before becoming pregnant. They should discuss their medication with their prescriber, and the pros and cons of continuing treatment. This includes non stimulant adhd medication-pharmacological methods. Psychoeducation is also required to help pregnant women with ADHD recognize the signs and underlying disorder. They should also be educated about treatment options and strengthen the coping mechanisms. This should include a multidisciplinary approach, which includes the GP, obstetricians and psychiatry. The pregnancy counselling should consist of the discussion of a plan for management for both the mother and child, monitoring for signs of deterioration and the need for adjustments to the medication regimen.